NCT05437588View on ClinicalTrials.gov

Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents

NARecruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

June 29, 2027

Study Completion Date

June 30, 2027

Conditions
Major Depressive DisorderSuicidal IdeasSuicide, AttemptedMDDDepressionDepression, TeenDepression and SuicideDepression in AdolescenceSuicide
Interventions
GENETIC

Genetic testing

Attempting to identify the genetic biomarker that can identify risk for suicidal ideation and action

Trial Locations (2)

35233

RECRUITING

University of Alabama at Birmingham, Birmingham

35294

RECRUITING

UAB Huntsville Regional Medical Campus, Huntsville

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Alabama at Birmingham

OTHER